AKT1 and cancer: Recent studies indicate that up-regulation of MDA-9/Syntenin may lead to cancer progression by binding to kinases or receptor on the plasma membrane and mediating the activation of P38/NF-κB, Smad signaling or the AKT pathway in several types of cancer [19–28].